EHR

1upHealth Launches 1up Clinical Connect to Help Payers Strengthen HEDIS Scores, Star Ratings, and Financial Performance with Continuous Clinical Data

Interoperability Leader Announces Capital Health Plan as Inaugural User of New Solution BOSTON, MA / ACCESS Newswire / September 1,...

Boehringer Ingelheim launches SCOVELLA® in Great Britain, the first approved therapy for insulin dysregulation in horses, a main cause of laminitis

Boehringer headquarters Ingelheim, Germany Ingelheim, Germany, and Bracknell, United Kingdom SCOVELLA® is the first therapy specifically developed and approved for...

error: Content is protected !!